IDO1 and neoplasm: Direct targeting of IDO with siRNA promoted antitumor immunity in vivo in a murine bladder tumor model (144) and IDO-silenced dendritic cells enhanced tumor antigen-specific T cell proliferation, cytotoxic activity, and decreased Treg numbers (145).